Matthew Fitzpatrick

Matthew Fitzpatrick's work experience begins in 2002 when they joined Cato Research as a Regulatory Affairs Associate II. Matthew worked there until 2009.

Matthew then worked at GSK as a Regulatory Submission Specialist for four years, from 2009 to 2013.

Afterward, they joined Pearl Therapeutics, where they served as a Manager, Regulatory Submissions from 2013 to 2017. Matthew then transitioned to the role of Regulatory Affairs Operations until 2018.

In 2021, they joined Latham BioPharm Group as a Consultant, Regulatory Operations until 2022.

Currently, they work at Aditum Bio as a Regulatory Project Manager from 2022 onwards.

Matthew Fitzpatrick attended Springfield College from 2001 to 2002, where they pursued a Bachelor of Science degree in Human Services, General.